Acknowledgement
Supported by : Board of Research in Nuclear Sciences
References
- Bruno AE, Li L, Kalabus JL, et al (2012). miRdSNP: a database of disease-associated SNPs and microRNA target sites on 3’UTRs of human genes. BMC Genomics, 13, 44. https://doi.org/10.1186/1471-2164-13-44
-
Cai J, Guan H, Fang L, et al (2013). MicroRNA-374a activates Wnt/
${\beta}$ -catenin signaling to promote breast cancer metastasis. J Clin Invest, 123, 566-79. - Cakmak HA, Coskunpinar E, Ikitimur B, et al (2015). The prognostic value of circulating microRNAs in heart failure: preliminary results from a genome-wide expression study. J Cardiovasc Med, 16, 431-7. https://doi.org/10.2459/JCM.0000000000000233
- Chang YY, Kuo WH, Hung JH, et al (2015). Deregulated microRNAs in triple-negative breast cancer revealed by deep sequencing. Mol Cancer, 14, 36. https://doi.org/10.1186/s12943-015-0301-9
- Chavali V, Tyagi SC, Mishra PK (2014). Differential expression of dicer, miRNAs, and inflammatory markers in diabetic Ins2+/− Akita hearts. Cell Biochem Biophys, 68, 25-35. https://doi.org/10.1007/s12013-013-9679-4
- Chen Y, Tang Y, Chen S, Nie D (2009). Regulation of drug resistance by human pregnane X receptor in breast cancer. Cancer Biol Ther, 8, 1265-72. https://doi.org/10.4161/cbt.8.13.8696
- Conde I, Lobo MV, Zamora J, et al (2008). Human pregnane X receptor is expressed in breast carcinomas, potential heterodimers formation between hPXR and RXR-alpha. BMC Cancer, 8, 174. https://doi.org/10.1186/1471-2407-8-174
- Dweep H, Gretz N (2015). miRWalk2. 0: a comprehensive atlas of microRNA-target interactions. Nat Methods, 12, 697. https://doi.org/10.1038/nmeth.3485
- Evans WE, McLeod HL (2003). Pharmacogenomics-drug disposition, drug targets, and side effects. New Engl J Med, 348, 538-49. https://doi.org/10.1056/NEJMra020526
-
Feliciano A, Castellvi J, Artero-Castro A, et al (2013). miR-125b acts as a tumor suppressor in breast tumorigenesis via its novel direct targets ENPEP, CK2-
${\alpha}$ , CCNJ, and MEGF9. PloS One, 8, 76247. https://doi.org/10.1371/journal.pone.0076247 - Ferlay J, Soerjomataram I, Ervik M, et al (2013). GLOBOCAN 2012 v1. 0, Cancer Incidence and Mortality Worldwide: IARC Cancer Base; International Agency for Research on Cancer.
- Honkakoski P, Negishi M (2000). Regulation of cytochrome P450 (CYP) genes by nuclear receptors. Biochem J, 347, 321-37. https://doi.org/10.1042/bj3470321
- Hughes TA (2006). Regulation of gene expression by alternative untranslated regions. Trends Genet, 22, 119-22. https://doi.org/10.1016/j.tig.2006.01.001
- Janssen EA, Slewa A, Gudlaugsson E, et al (2010). Biologic profiling of lymph node negative breast cancers by means of microRNA expression. Mod Pathol, 23, 1567-76. https://doi.org/10.1038/modpathol.2010.177
- Karagiannis GS, Weile J, Bader GD, Minta J (2013). Integrative pathway dissection of molecular mechanisms of moxLDLinduced vascular smooth muscle phenotype transformation. BMC Cardiovasc Disord, 13, 4. https://doi.org/10.1186/1471-2261-13-4
- Kotta-Loizou I, Patsouris E, Theocharis S (2013). Pregnane X receptor polymorphisms associated with human diseases. Expert opin Ther Targets, 17, 1167-77. https://doi.org/10.1517/14728222.2013.823403
- Lal S, Mahajan A, Ning Chen W, Chowbay B (2010). Pharmacogenetics of target genes across doxorubicin disposition pathway: a review. Curr Drug Metab, 11, 115-28. https://doi.org/10.2174/138920010791110890
- Lee YM, Lee JY, Ho CC, et al (2011). miRNA-34b as a tumor suppressor in estrogen-dependent growth of breast cancer cells. Breast Cancer Res, 13, 116. https://doi.org/10.1186/bcr3059
- Li N, Yang L, Wang H, et al (2015). miR-130a and miR-374a function as novel regulators of cisplatin resistance in human ovarian cancer a2780 cells. PloS One, 10, 128886.
- Lin Y, Liu AY, Fan C, et al (2015). MicroRNA-33b inhibits breast cancer metastasis by targeting HMGA2, SALL4 and Twist1. Sci Rep, 5, 9995. https://doi.org/10.1038/srep09995
- Liu C, Zhang F, Li T, et al (2012). MirSNP, a database of polymorphisms altering miRNA target sites, identifies miRNA-related SNPs in GWAS SNPs and eQTLs. BMC Genomics, 13, 661. https://doi.org/10.1186/1471-2164-13-661
- Masuyama H, Nakatsukasa H, Takamoto N, Hiramatsu Y (2007). Down-regulation of pregnane X receptor contributes to cell growth inhibition and apoptosis by anticancer agents in endometrial cancer cells. Mol Pharmacol, 72, 1045-53. https://doi.org/10.1124/mol.107.037937
- Nilsson S, Allred C, Howell A, Landberg G (2011). Stromal and epithelial microRNA signatures of early breast lesions linked to cancer progression. Cancer Res, 71, 3993. https://doi.org/10.1158/1538-7445.AM2011-3993
- Oleson L, von Moltke LL, Greenblatt DJ, Court MH (2010). Identification of polymorphisms in the 3'-untranslated region of the human pregnane X receptor (PXR) gene associated with variability in cytochrome P450 3A (CYP3A) metabolism. Xenobiotica, 40, 146-62. https://doi.org/10.3109/00498250903420243
- Omran A, Elimam D, Webster KA, Shehadeh LA, Yin F (2013). MicroRNAs: a new piece in the paediatric cardiovascular disease puzzle. Cardiol Young, 23, 642-55. https://doi.org/10.1017/S1047951113000048
- Pondugula SR, Mani S (2013). Pregnane xenobiotic receptor in cancer pathogenesis and therapeutic response. Cancer Lett, 328, 1-9. https://doi.org/10.1016/j.canlet.2012.08.030
- Qiao EQ, Yang HJ (2014). Effect of pregnane X receptor expression on drug resistance in breast cancer. Oncol Lett, 7, 1191-96. https://doi.org/10.3892/ol.2014.1817
- Schlitt A, Jordan K, Vordermark D, et al (2014). Cardiotoxicity and oncological treatments. Dtsch Arztebl Int, 111, 161-8.
- Singal PK, Iliskovic N (1998). Doxorubicin-induced cardiomyopathy. N Engl J Med, 339, 900-5. https://doi.org/10.1056/NEJM199809243391307
- Swart M, Dandara C (2013). Genetic variation in the 3'-UTR of CYP1A2, CYP2B6, CYP2D6, CYP3A4, NR1I2, and UGT2B7: potential effects on regulation by microRNA and pharmacogenomics relevance. Front Genet, 5, 167.
- Takagi S, Nakajima M, Mohri T, Yokoi T (2008). Posttranscriptional regulation of human pregnane X receptor by micro-RNA affects the expression of cytochrome P450 3A4. J Biol Chem, 283, 9674-80. https://doi.org/10.1074/jbc.M709382200
- Van den Hoogen P, van den Akker F, Deddens JC, Sluijter JP (2015). Heart Failure in Chronic Myocarditis: A Role for microRNAs?. Curr Genomics, 16, 88-94. https://doi.org/10.2174/1389202916999150120153344
- Van Schooneveld E, Wildiers H, Vergote I, et al (2015). Dysregulation of microRNAs in breast cancer and their potential role as prognostic and predictive biomarkers in patient management. Breast Cancer Res, 17, 21. https://doi.org/10.1186/s13058-015-0526-y
- Vlachos IS, Kostoulas N, Vergoulis T, et al (2012). DIANA miRPath v. 2.0: investigating the combinatorial effect of microRNAs in pathways. Nucleic Acids Res, 40, 498-504. https://doi.org/10.1093/nar/gks494
- Wang Y, Gu X, Li Z, et al (2013). microRNA expression profiling in multidrug resistance of the 5‑Fu‑induced SGC‑7901 human gastric cancer cell line. Mol Med Rep, 7, 1506-10. https://doi.org/10.3892/mmr.2013.1384
- Wang J, Pei Y, Zhong Y, et al (2014). Altered serum microRNAs as novel diagnostic biomarkers for atypical coronary artery disease. PloS One, 9, 107012. https://doi.org/10.1371/journal.pone.0107012
- Wang JX, Zhang XJ, Feng C, et al (2015). MicroRNA-532-3p regulates mitochondrial fission through targeting apoptosis repressor with caspase recruitment domain in doxorubicin cardiotoxicity. Cell Death Dis, 6, 1677. https://doi.org/10.1038/cddis.2015.41
-
Xing Y, Liu Z, Yang G, Gao D, Niu X (2015). MicroRNA expression profiles in rats with selenium deficiency and the possible role of the Wnt/
${\beta}$ ‑catenin signaling pathway in cardiac dysfunction. Int J Mol Med, 35, 143-52. https://doi.org/10.3892/ijmm.2014.1976 - Zhang J, Kuehl P, Green ED, et al (2001). The human pregnane X receptor: genomic structure and identification and functional characterization of natural allelic variants. Pharmacogenetics, 11, 555-72. https://doi.org/10.1097/00008571-200110000-00003
- Zhang J, Wang Y, Zhen P, et al (2013). Genome-wide analysis of miRNA signature differentially expressed in doxorubicinresistant and parental human hepatocellular carcinoma cell lines. PLoS One, 8, 54111. https://doi.org/10.1371/journal.pone.0054111